Connect with us

Pregnancy

Understanding the contraception crisis

How the one-size-fits-all approach fails women and why it has to change

Published

on

Finding the right contraception method shouldn’t be trial and error, says Elena Rueda Carrasco. She tells FemTech World why understanding contraception is more important than ever. 

“Despite encouraging research, a male birth control pill remains elusive,” reads a recent headline in The New York Times.

Although, according to the article, scientists have been researching ways to create a male birth control pill since the 1970s, negative side effects, such as weight gain, acne, irritability and mood swings, have been responsible for not licensing any products for use.

“A woman can struggle with the same symptoms in silence – something rather normalised in our society,” says Elena Rueda Carrasco, medical scientist and co-founder and CEO of Dama Health, a company that offers personalised contraception recommendation. “Many women are being told from a very young age that the pain they are experiencing is normal,” she adds.

Indeed birth control side effects, such as weight gain, mood changes and headaches, affect eight in ten women, but are yet deemed too dangerous for developing a pill for men.

“The side effects and the impact of different contraception methods on women have been very normalised when you compare it to other areas of medicine,” Rueda explains. “In a lot of cases, women end up with conditions like endometriosis and PCOS – polycystic ovary syndrome – because their symptoms are often ignored and early diagnosis is not achieved.”

Elena Rueda Carrasco, co-founder and CEO of Dama Health

Figures suggest that medical consultations are too short to offer the right guidance and on average, women try 3.5 different contraceptive methods before finding the one that works for them.

“In the UK, we have such a fragmented [health] system,” the co-founder says. “As a woman, you can get your contraception through your GP, you can go to a sexual health clinic, you can speak to a nurse or a pharmacist. And from our own research, we found out that for many women, this is very confusing.

“Most of the time women will probably call or visit their GP and the GP is actually not a specialist,” Rueda points out. “The GPs are doing a bit of everything, with just a couple of contraception methods they’re comfortable prescribing. Therefore, communication is really hard when you have this fragmentation happening and you don’t really know where to go and who to speak to”.

Dama Health aims to personalise and tailor the way women are being prescribed contraception, screening for and identifying the side effects that women might experience individually. An algorithm would then match them to the recommended contraceptive options that are most suitable for them.

“As a team, we are all scientists and doctors by background, and we were all experiencing this problem of trial and error in the way that women were being prescribed hormonal medication and in this specific case, contraception,” the CEO says.

“I think it all came from personal experience and we all felt that it was an issue. Our chief medical officer, Dr Aaron Lazorwitz, is an OBGYN doctor and he experienced it in clinic, whereas myself and Paulina Cecula [her co-founder] experienced it as women. Paulina is also a medic and she was seeing that actually, doctors were having difficulties and the whole thing ended up being like ‘try this and come back if there’s a problem’.

“We thought that there’s a huge inefficiency [within the system] in this day and age. Women shouldn’t be having to trial and error to find if something is good for them,” Rueda adds. “So that drove us to start doing screening tests, making everything a lot more personal and helping the medical community to make the best decisions when it comes to contraception methods.”

She says that at the heart of this, education and communication are extremely important. “Women and young adults need to be educated around the topic of contraception better,” the CEO says.

“Women especially feel unable to verbalise how they feel, they can’t actually communicate it. So part of our solutions through the screening process, is to ask the right questions that help women understand their bodies and have a better conversation with their doctor.

“For that reason, I think personalised medicine is the future because actually, this one-size-fits-all approach isn’t working. When it comes to medication, you really do need to get that personalisation because the inside of us is so different and so unique.

“With technology becoming cheaper, we have the tools and the ability to make it more personalised and that essentially means taking into account medical history, preferences, maybe some biomarker information and just putting them together to be able to tailor the right treatment option.”

Experts like Rueda believe that very often huge amounts of data are being lost because of a lack of a data tracking system and that subsequently, makes the entire research process harder. “A doctor doesn’t tell you ‘Hey, try this contraception and tell me how you feel’ and actually write a report on it,” she explains. “That information is, therefore, not being captured. That’s dangerous because so much information is not being taken into account.”

But how could data tracking help the medical world? “A doctor is always going to use quantitative and qualitative data to make decisions, so symptom-tracking is one of the most powerful things that we can do as patients,” Rueda adds. “Data has so much power because it helps you essentially prove your point in an argument and is the fastest way to get information and to accelerate research.”

Walking into the clinic, as a woman, and feeling empowered is something that the CEO would like to see in the future and she also hopes that her company will support all women equally.

“The most important thing [for Dama Health] is to be able to be as accessible as possible and help women from different backgrounds. That impact is really important for us and also just working with the medical community and trying to implement our screening tests that could be easily accessed by anyone.”

The team will also be recruiting for beta testers and clinical in Q4 of 2022. If you are UK-based, you can sign-up here to be part of future clinical trials and research programmes.

For more info, visit damahealth.com.

 

 

Fertility

Maternal antibodies protect against newborn infection

Published

on

Maternal antibodies may protect babies from severe newborn infection caused by E. coli, after a study found the sickest infants had far lower levels.

A multi-centre study has shed new light on why some newborns become severely ill from Escherichia coli, or E. coli, while others do not.

The findings suggest most babies are protected by germ-fighting antibodies passed on by their mothers.

Sing Sing Way, an expert on immune system changes in expecting mothers and babies in the division of infectious diseases at Cincinnati Children’s and senior author on the study, said: “This helps explain long-standing question: if most babies are exposed to germs soon after birth, why don’t even more develop severe infection?

Our findings provide key missing piece to this puzzle, the antibodies stimulated by the presence of these common bacteria in our intestines protect us against infection. 

“In pregnancythe natural transfer of these germfighting antibodies from mothers to babies in the womb protect the vast majority against infection.

In the rare situation when these antibodies are low in mothers or inefficiently transferred, babies are at much higher risk for infection.”

The study examined why only some babies develop severe infection from common bacteria.

E. coli is a common bacterium that lives in the intestines of nearly all people and is a leading cause of severe infection in newborn babies.

The research found that the babies who became most severely ill from E. coli infection also had markedly lower levels of germ-fighting antibodies transferred from their mothers.

The multi-centre research was led by Cincinnati Children’s, in collaboration with the University of Queensland in Australia, the University of Texas Southwestern Medical Center, Children’s Mercy Kansas City and the University of Missouri Kansas City School of Medicine.

To conduct the study, researchers retrieved dried blood samples collected during routine newborn screening from 100 babies who eventually developed E. coli infection and compared their antibody levels with those of hundreds of other infants who did not.

The analysis found that antibodies targeting E. coli were consistently reduced in infected babies. Because E. coli can vary widely, the researchers used a panel of strains isolated from infected babies to assess levels of these germ-fighting antibodies.

In a separate part of the study, the researchers used mice raised without any exposure to E. coli and therefore lacking the relevant antibodies.

They found that introducing a probiotic strain of E. coli, called Nissle 1917, to mice before pregnancy stimulated production of protective antibodies that efficiently protected newborn mice against infection.

The probiotic is widely available for human use in Europe, Asia and Australia under the trade name Mutaflor.

Mark Schembri, co-author and researcher at the Institute for Molecular Bioscience at the University of Queensland, said: “Understanding protection takes both types of evidence, what we can evaluate from specimens in human babies that naturally develop infection, and what we can test by experimentally causing infection.

By strategically combining real-world human newborn screening samples with carefully designed infection models, we can start to pinpoint which antibody targets matter most and how broad protection might be achieved.”

Susana Chavez-Bueno, co-author from Children’s Mercy Hospital in Kansas City, said: “Neonatal sepsis can escalate quickly, and clinicians need better ways to identify which infants are at highest risk. These findings suggest a path toward earlier risk recognition and eventually, prevention strategies built around restoring the missing protective maternal antibodies.”

The researchers said they plan to develop a screening test to identify newborns at highest risk of severe E. coli infection, and eventually a probiotic that could be safe for mothers and strengthen their own immunity as well as the immunity transferred to their babies.

Continue Reading

Pregnancy

Pregnancy complications and stress linked to long-term cardiovascular risk

Published

on

Pregnancy complications may leave women more vulnerable to the long-term heart effects of stress, a recent study suggests.

A study of more than 3,000 women in their first pregnancy found persistently higher stress levels were associated with higher blood pressure after pregnancy, specifically in women who had adverse pregnancy outcomes including preeclampsia, preterm birth, having a baby that was small for gestational age, meaning smaller than expected for that stage of pregnancy, or stillbirth.

Among women who experienced these complications, higher stress levels over time were associated with blood pressure that was 2 mm Hg higher than that of the low-stress group during the years two to seven after delivery.

This was not the case among women who did not experience adverse pregnancy outcomes.

Virginia Nuckols, lead author of the study and a postdoctoral fellow in the University of Delaware’s department of kinesiology and applied physiology, said: “For women who were having babies for the first time and had complications, referred to as adverse pregnancy outcomes, we found that higher stress levels over time were associated with higher blood pressure levels 2-to-7 years after delivery.

“This suggests that women who had pregnancy complications may be more susceptible to the negative effects of stress on their heart health, and taking steps to manage and reduce stress could be important for protecting long-term heart health.”

The researchers analysed records of 3,322 first-time mothers aged 15 to 44 who did not have high blood pressure before pregnancy.

The women were enrolled at 17 medical centres in eight US states, were pregnant with one baby and were having their first child. According to the authors, 66 per cent of participants self-identified as white, 14 per cent as Hispanic and 11 per cent as Black.

Blood pressure and stress levels were measured during the first and third trimesters, and again two to seven years after delivery.

Stress was assessed using the Perceived Stress Scale, a standard questionnaire that asks how often people feel situations are uncontrollable, unpredictable or overwhelming.

Those who experienced moderate to high stress levels were often younger, between 25 and 27 years of age, had higher body mass index, a measure based on height and weight, and lower educational attainment.

The authors said it is not yet clear exactly how higher stress leads to higher blood pressure in women who had pregnancy complications, and that several factors are likely to be involved.

Nuckols added: “Future studies should examine why women with a history of adverse pregnancy outcomes may be more susceptible to stress-driven increases in blood pressure and test whether stress reduction interventions can actually lower cardiovascular risk for these women.”

High blood pressure during pregnancy can have lasting effects on maternal health, including preeclampsia, eclampsia, stroke or kidney problems, according to the American Heart Association’s 2025 guideline for the prevention, detection, evaluation and management of high blood pressure in adults.

Monitoring blood pressure before, during and after pregnancy is crucial to help prevent and reduce the risk of long-term complications.

Laxmi Mehta is chair of the American Heart Association’s Council on Clinical Cardiology and director of preventive cardiology and women’s cardiovascular health at The Ohio State University Wexner Medical Center, and was not involved in the study.

Mehta said;’ “This study highlights the powerful connection between the mind and heart, emphasising the importance of stress management, particularly for those who have experienced adverse pregnancy outcomes.

“For the clinical care team, it reinforces the need to proactively assess and address stress as part of the comprehensive care we provide to our patients.

“Future research on whether targeted interventions to reduce or manage stress has a meaningful impact on long-term cardiovascular outcomes will be important as well.”

Continue Reading

Fertility

Second pregnancy alters the female brain

Published

on

A second pregnancy alters the female brain in ways distinct from a first, according to research examining how motherhood affects brain structure and function.

The study tracked 110 women using repeated brain scans. Some became mothers for the first time, others had a second child, while a third group remained childless, allowing researchers to identify pregnancy-related brain changes.

During a first pregnancy, the greatest changes occurred in the default mode network, a brain system involved in self-reflection and social processes. During a second pregnancy, this network changed again, but less strongly.

Instead, a second pregnancy was associated with more changes in brain networks linked to directing attention and responding to stimuli, functions that may be useful when caring for more than one child.

Each pregnancy produced both shared and distinct effects on the brain, with patterns differing between first and second pregnancies.

Elseline Hoekzema, head of the Pregnancy Brain Lab at Amsterdam UMC, said: “With this, we have shown for the first time that the brain not only changes during the first pregnancy, but also during a second. During a first and second pregnancy, the brain changes in both similar and unique ways. Each pregnancy leaves a unique mark on the female brain.”

Milou Straathof, a researcher who analysed the data, said: “It appears that during a second pregnancy, the brain is more strongly altered in networks involved in reacting to sensory cues and in controlling your attention. These processes may be beneficial when caring for multiple children.”

The researchers also found a link between brain changes and the bond between mother and child, which was more pronounced during a first pregnancy than a second. They also observed associations between structural brain changes and peripartum depression, a form of depression that can occur during pregnancy or after birth, in both first and second pregnancies.

This provides the first evidence that changes in the cortex, the brain’s outer layer, during pregnancy are linked to maternal depression.

For women who became mothers for the first time, this link was especially visible after childbirth. For women having their second child, it was particularly apparent during pregnancy.

The researchers said: “This knowledge can help to better understand and recognise mental health problems in mothers. It is important that we understand how the brain adapts to motherhood.

They added that the findings could support better care for mothers, including the prevention and treatment of postnatal depression. Although most women experience pregnancy once or multiple times, scientists are only beginning to understand how it affects the brain.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.